Patents by Inventor Eric Andre

Eric Andre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109889
    Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Application
    Filed: September 19, 2023
    Publication date: April 4, 2024
    Applicant: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
  • Publication number: 20240105967
    Abstract: The invention relates to a bipolar plate for a fuel cell stack that extends in a vertical plane in the use position, the plate comprising opposed first and second transverse edges, upper and lower longitudinal edges, a central region arranged between the edges, a first opening for a heat transfer fluid inlet, a second opening for heat transfer fluid collection a third opening for an oxidant inlet, a fourth opening for oxidant collection, a fifth opening for the inlet of a fuel, a sixth opening for fuel collection, wherein the first, third and sixth openings are arranged in the first transverse edge and are arranged axially in relation to one another, the second, fourth and fifth openings are arranged in the second transverse edge and are arranged axially in relation to one another, and, in the vertical position of use of the plate: the sixth opening are arranged below the first and third openings, the fourth opening is arranged below the second and fifth openings, and the second opening is arranged above the
    Type: Application
    Filed: November 17, 2023
    Publication date: March 28, 2024
    Applicant: L'Air Liquide, Societe Anonyme pour l'Etude et l’Exploitation des Procedes Georges Claude
    Inventors: Johan ANDRE, Camille BOUVIER, Eric CLAUDE, Nicolas JANNIN, Denis SIRAC, Didier ZAEPFFEL
  • Patent number: 11938584
    Abstract: A chemical mechanical polishing pad includes a surface portion of a first material. The surface portion includes a plurality of grooves. A first portion of the grooves are exposed grooves located at a surface of the chemical mechanical polishing pad. A second portion of the grooves are buried grooves embedded below the surface of the chemical mechanical polishing pad, such that, during use of the chemical mechanical polishing pad, one or more of the buried grooves are exposed at the surface.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: March 26, 2024
    Assignee: CMC MATERIALS LLC
    Inventors: Paul Andre Lefevre, Devin Schmitt, Jaeseok Lee, Eric S. Moyer, Holland Hodges
  • Patent number: 11897486
    Abstract: Techniques described are related to determining when a discrepancy between data of multiple sensors (e.g., IMUs) might be attributable to a sensor error, as opposed to operating conditions, such as sensor bias or noise. For example, the sensor data is passed through one or more filters (e.g., bandpass filter) that model the bias or noise, and the filtered data may then be compared for consistency. In some examples, consistency may be based on residuals or some other metric describing discrepancy among the filtered sensor data.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: February 13, 2024
    Assignee: ZOOX, INC.
    Inventors: Derek Adams, Eric Andre Senant, Weihung Ko, Michael Carsten Bosse
  • Patent number: 11802131
    Abstract: The present invention provides selected glutarimides which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: October 31, 2023
    Assignee: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Philipp Schmid, Fabian Dey, Eric Andre Kusznir
  • Patent number: 11787802
    Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: October 17, 2023
    Assignee: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
  • Patent number: 11757686
    Abstract: In an embodiment a device includes a first circuit and a second circuit, wherein the first circuit is configured to generate a fourth signal and a fifth signal by applying the phase shift respectively to a first signal and to a second signal and deliver a sixth signal corresponding to a sampling over one bit of the fourth signal, a seventh signal corresponding to a sampling over one bit of the fifth signal, an eighth signal corresponding to a sampling over one bit of a difference between the fourth and fifth signals, and a ninth signal corresponding to a sampling over one bit of a sum between the fourth and fifth signals, wherein the second circuit is configured to receive the sixth, seventh, eighth, and ninth signals and determine, during a first phase where the first and second signals are representative of a first known symbol of a QPSK constellation, a state of a first bit from among a first state and a second state based on the eighth and ninth signals.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: September 12, 2023
    Assignee: STMicroelectronics SA
    Inventors: Eric Andre, Lionel Vogt
  • Publication number: 20230192643
    Abstract: The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Application
    Filed: August 1, 2022
    Publication date: June 22, 2023
    Applicant: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Adrian Britschgi, Fabian Dey, Annick Goergler, Eric Andre Kusznir, Moreno Attilio Wichert
  • Publication number: 20230082027
    Abstract: A radar system is provided based on a core module comprising a radar transducer based on a long, flat platform, provided with coupling elements at each end, which may comprise ISO standard compatible corner fittings as used in freight containers Accessory modules may be connected to the core module by means of these coupling elements at each end. Accessory modules may provide power, communications, cooling or other support functions as required. The coupling achieved between the core module and accessory modules may be reinforced with side brackets, and may be sufficiently strong that the weight of the complete assembly may be supported by the core module, or by the accessory modules. The combined length of the core module and accessory modules may be elected to correspond essentially to the length of a standard freight container, and the length of the core module alone may be selected to correspond to the flat bed of a standard medium truck.
    Type: Application
    Filed: February 10, 2020
    Publication date: March 16, 2023
    Inventors: Edwin Leonardus Josephus HOGEMAN, Eric André KAPPEL
  • Publication number: 20230034119
    Abstract: In an embodiment a device includes a first circuit and a second circuit, wherein the first circuit is configured to generate a fourth signal and a fifth signal by applying the phase shift respectively to a first signal and to a second signal and deliver a sixth signal corresponding to a sampling over one bit of the fourth signal, a seventh signal corresponding to a sampling over one bit of the fifth signal, an eighth signal corresponding to a sampling over one bit of a difference between the fourth and fifth signals, and a ninth signal corresponding to a sampling over one bit of a sum between the fourth and fifth signals, wherein the second circuit is configured to receive the sixth, seventh, eighth, and ninth signals and determine, during a first phase where the first and second signals are representative of a first known symbol of a QPSK constellation, a state of a first bit from among a first state and a second state based on the eighth and ninth signals.
    Type: Application
    Filed: July 29, 2022
    Publication date: February 2, 2023
    Inventors: Eric Andre, Lionel Vogt
  • Patent number: 11526444
    Abstract: A method for facilitating predictive caching of data is provided. The method includes retrieving raw data relating to user activity for a plurality of users, the user activity including a history of web resources accessed by a user; converting the raw data into a structured data set based on a predetermined criterion; generating a model based on the structured data set; training the model by using a training data set, the training data set including the user activity for a predetermined period of time; determining, by using the trained model, a predicted first web resource for the user; and automatically caching, in a memory, the predicted first web resource.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: December 13, 2022
    Assignee: JPMorgan Chase Bank, N.A.
    Inventors: Ramin Koch, Eric-Andre Vigroux, Liang Zhou, Mathieu Cliche, Yihui Tang, Howard Spector, Rebecca Setting, Neil V O'Donnell, Timothy Lorenz
  • Publication number: 20220289738
    Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Application
    Filed: January 14, 2022
    Publication date: September 15, 2022
    Applicant: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
  • Patent number: 11445457
    Abstract: A wireless communication system is provided including a first media device, a second media device, and a third media device, each media device configured to output media content. The first media device is designated as an access point media device that is configured to transmit media content to the second media device and the third media device. The first media device is configured to transmit the media content to the second media device using simplex communication instead of duplex communication based on a first confidence level indicator received from the second media device indicating a high level of confidence. The first media device is configured to transmit the media content to the third media device using duplex communication based on a second confidence level indicator received from the third media device a high level of confidence, and each media device is configured to output the media content in a synchronized manner.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: September 13, 2022
    Assignee: Logitech Europe S.A.
    Inventors: Eric Andre Tissot-Dupont, Vasanth Prabhakar Murari, Edison Liwanag David
  • Patent number: 11418559
    Abstract: A wireless communication system is provided including a group of media devices that includes a first media device, a second media device, a third media device, and a fourth media device. The first media device, during a first time period, is designated as an access point media device that is configured to transmit media content to each of the other media devices in the group. The second media device is configured to become the access point media device during a second time period and transmit media content to each of the other media devices in the group based on a determination that the second media device is better suited than the first media device to be the access point media device for the group during the second time period. Each media device is configured to output the media content transmitted by the access point media device in a synchronized manner.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: August 16, 2022
    Assignee: LOGITECH EUROPE S.A.
    Inventors: Eric Andre Tissot-Dupont, Vasanth Prabhakar Murari, Edison Liwanag David
  • Patent number: 11401256
    Abstract: The present invention provides dihydroquinolinone compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: August 2, 2022
    Assignee: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Adrian Britschgi, Fabian Dey, Annick Goergler, Eric Andre Kusznir, Moreno Attilio Wichert
  • Publication number: 20220094726
    Abstract: A wireless communication system is provided including a group of media devices that includes a first media device, a second media device, a third media device, and a fourth media device. The first media device, during a first time period, is designated as an access point media device that is configured to transmit media content to each of the other media devices in the group. The second media device is configured to become the access point media device during a second time period and transmit media content to each of the other media devices in the group based on a determination that the second media device is better suited than the first media device to be the access point media device for the group during the second time period. Each media device is configured to output the media content transmitted by the access point media device in a synchronized manner.
    Type: Application
    Filed: September 21, 2020
    Publication date: March 24, 2022
    Inventors: Eric Andre TISSOT-DUPONT, Vasanth Prabhakar MURARI, Edison Liwanag DAVID
  • Publication number: 20220095249
    Abstract: A wireless communication system is provided including a first media device, a second media device, and a third media device, each media device configured to output media content. The first media device is designated as an access point media device that is configured to transmit media content to the second media device and the third media device. The first media device is configured to transmit the media content to the second media device using simplex communication instead of duplex communication based on a first confidence level indicator received from the second media device indicating a high level of confidence. The first media device is configured to transmit the media content to the third media device using duplex communication based on a second confidence level indicator received from the third media device a high level of confidence, and each media device is configured to output the media content in a synchronized manner.
    Type: Application
    Filed: September 21, 2020
    Publication date: March 24, 2022
    Inventors: Eric Andre TISSOT-DUPONT, Vasanth Prabhakar MURARI, Edison Liwanag DAVID
  • Publication number: 20220066932
    Abstract: A method for facilitating predictive caching of data is provided. The method includes retrieving raw data relating to user activity for a plurality of users, the user activity including a history of web resources accessed by a user; converting the raw data into a structured data set based on a predetermined criterion; generating a model based on the structured data set; training the model by using a training data set, the training data set including the user activity for a predetermined period of time; determining, by using the trained model, a predicted first web resource for the user; and automatically caching, in a memory, the predicted first web resource.
    Type: Application
    Filed: August 26, 2021
    Publication date: March 3, 2022
    Applicant: JPMorgan Chase Bank, N.A.
    Inventors: Ramin KOCH, Eric-Andre VIGROUX, Liang ZHOU, Mathieu CLICHE, Yihui TANG, Howard SPECTOR, Rebecca SETTING, Neil V O'DONNELL, Su AMARATUNGA, Andy HOUSTON, Timothy LORENZ
  • Patent number: 11254672
    Abstract: The present invention provides selected dihydrobenzimidazolones which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: February 22, 2022
    Assignee: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Fabian Dey, Eric Andre Kusznir
  • Publication number: 20200207783
    Abstract: The present invention provides selected glutarimides which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. The disclosed compounds are useful for the treatment of cancer.
    Type: Application
    Filed: March 4, 2020
    Publication date: July 2, 2020
    Applicant: C4 Therapeutics, Inc.
    Inventors: Roger Norcross, Annick Goergler, Philipp Schmid, Fabian Dey, Eric Andre Kusznir